Vol. 40 No. 5 (2023): Octubre
Original Article

Profile of adult patients hospitalized with COVID-19 before and after introduction of SARS-CoV-2 vaccines

Marcela Potin
Pontificia Universidad Católica de Chile
Bio
Sofía Aljaro
Pontificia Universidad Católica de Chile
Bio
Sofía López
Universidad San Sebastián
Bio
Olga Uauy
Pontificia Universidad Católica de Chile
Bio
Constanza Cifuentes
Pontificia Universidad Católica de Chile
Bio
Jaime Cerda
Pontificia Universidad Católica de Chile
Bio
Daniel Valenzuela
Pontificia Universidad Católica de Chile
Bio

Published 2023-10-12

How to Cite

1.
Potin M, Aljaro S, López S, Uauy O, Cifuentes C, Cerda J, Valenzuela D. Profile of adult patients hospitalized with COVID-19 before and after introduction of SARS-CoV-2 vaccines. Rev. Chilena. Infectol. [Internet]. 2023 Oct. 12 [cited 2026 Jan. 16];40(5). Available from: https://www.revinf.cl/index.php/revinf/article/view/1809

Abstract

Background: During the COVID-19 pandemic, the early prioritization of SARS-CoV-2 vaccines  for older adults may have affected the characteristics of hospitalized COVID-19 patients over time. Aim: To compare the clinical characteristics and outcomes of adult patients admitted


for COVID-19 before (PER1) and after (PER2) the initiation of mass vaccination for SARS-CoV-2. Methods: Data on age, gender, comorbidities, complications, and outcomes of adult patients hospitalized for COVID-19 in a private clinic were collected. Scores for COVID-19 severity and nutritional risk were calculated. Results: In PER2, patients were younger but had similar comorbidities, except for a higher prevalence of overweight and obesity compared to PER1. Unvaccinated COVID-19 patients in PER2 required more invasive ventilatory support (38.9% vs. 14.3%, p = 0.03) and had a higher severity score (six) than vaccinated patients (five, p = 0.048). The variables that best predicted mortality were age ≥ 60 years (OR 28,995) and the presence of nutritional risk (OR 5,246). Discussion: Changes in the profile and outcomes of hospitalized patients during the COVID-19 pandemic are associated with the prioritization of SARS-CoV-2 vaccines and their protective effect in reducing hospitalizations and disease severity in older adults.